Trials / Completed
CompletedNCT01268111
Effect of Vitamin D Replacement on Insulin Sensitivity
Effect of Vitamin D Supplementation on Insulin Sensitivity and Retinol-binding Protein 4 Levels in Subjects With Vitamin D Deficiency
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Texas Tech University Health Sciences Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Healthy subjects with low Vitamin D levels will be randomly assigned to either Vitamin D replacement or placebo for a period of 8 weeks. Insulin sensitivity will be measured before and after the intervention, and the changes will be compared between the two groups. This will help us understand if Vitamin D replacement improves insulin sensitivity. Serum Retinol Binding Protein 4 levels will also be measured to see if changes in insulin sensitivity are mediated by RBP4.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ergocalciferols | ERgocaclciferol 50,000 units weekly for 8 weeks |
| DRUG | Placebo | matching placebo |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2010-12-29
- Last updated
- 2015-06-08
- Results posted
- 2013-05-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01268111. Inclusion in this directory is not an endorsement.